Devika Das, Associate Professor of Medicine at the University of Florida College of Medicine, shared a post on LinkedIn about recent paper she and colleagues co-authored published in Journal of Clinical Oncology.
“Several TKIs can inhibit OCT2 and MATE1, leading to elevated serum creatinine levels without affecting the GFR, a phenomenon known as pseudo-acute kidney injury. Sharing our correspondence regarding the same- highlighting this clinical challenge.
Cystatin C clearance helps in testing: pearl for SOC and clinical trials.”
Title: Afatinib, Dose Reduction, and Pseudo-Acute Kidney Injury
Authors: Jacqueline Nguyen, Devika Das, Chintan V. Shah
Read The Full Article at Journal of Clinical Oncology.
More posts featuring Devika Das.